{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:45:03Z","timestamp":1791773103402,"version":"4.3.4"},"reference-count":26,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2017,9,30]],"date-time":"2017-09-30T00:00:00Z","timestamp":1506729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background &amp; Aims<\/jats:title>\n                    <jats:p>Recent studies suggest that heparins reduce liver fibrosis and the risk of decompensation of liver disease. Here, we evaluated the effects of enoxaparin in several experimental models of advanced cirrhosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Cirrhosis was induced in male Sprague\u2010Dawley (\n                      <jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content>\n                      ) rats by: (i) Oral gavage with carbon tetrachloride (\n                      <jats:styled-content style=\"fixed-case\">CC<\/jats:styled-content>\n                      l4\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:sub>ORAL<\/jats:sub>\n                      <\/jats:styled-content>\n                      ), (ii) Bile duct ligation (\n                      <jats:styled-content style=\"fixed-case\">BDL<\/jats:styled-content>\n                      ) and (iii)\n                      <jats:styled-content style=\"fixed-case\">CC<\/jats:styled-content>\n                      l4 inhalation (\n                      <jats:styled-content style=\"fixed-case\">CC<\/jats:styled-content>\n                      l4\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:sub>INH<\/jats:sub>\n                      <\/jats:styled-content>\n                      ). Rats received saline or enoxaparin s.c. (40\u00a0\n                      <jats:styled-content style=\"fixed-case\">IU<\/jats:styled-content>\n                      \/Kg\/d or 180\u00a0\n                      <jats:styled-content style=\"fixed-case\">IU<\/jats:styled-content>\n                      \/Kg\/d) following various protocols. Blood biochemical parameters, liver fibrosis, endothelium\u2010 and fibrosis\u2010related genes, portal pressure, splenomegaly, bacterial translocation, systemic inflammation and survival were evaluated. Endothelial dysfunction was assessed by in situ bivascular liver perfusions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Enoxaparin did not ameliorate liver function, liver fibrosis, profibrogenic gene expression, portal hypertension, splenomegaly, ascites development and infection, serum\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u20106 levels or survival in rats with\n                      <jats:styled-content style=\"fixed-case\">CC<\/jats:styled-content>\n                      l4\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:sub>ORAL<\/jats:sub>\n                      <\/jats:styled-content>\n                      or\n                      <jats:styled-content style=\"fixed-case\">BDL<\/jats:styled-content>\n                      \u2010induced cirrhosis. Contrarily, enoxaparin worsened portal pressure in\n                      <jats:styled-content style=\"fixed-case\">BDL<\/jats:styled-content>\n                      rats and decreased survival in\n                      <jats:styled-content style=\"fixed-case\">CC<\/jats:styled-content>\n                      l4\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:sub>ORAL<\/jats:sub>\n                      <\/jats:styled-content>\n                      rats. In\n                      <jats:styled-content style=\"fixed-case\">CC<\/jats:styled-content>\n                      l4\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:sub>INH<\/jats:sub>\n                      <\/jats:styled-content>\n                      rats, enoxaparin had no effects on hepatic endothelial dysfunction, except for correcting the hepatic arterial dysfunction when enoxaparin was started with the\n                      <jats:styled-content style=\"fixed-case\">CC<\/jats:styled-content>\n                      l4 exposure. In these rats, however, enoxaparin increased liver fibrosis and the absolute values of portal venous and sinusoidal resistance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results do not support a role of enoxaparin for improving liver fibrosis, portal hypertension or endothelial dysfunction in active disease at advanced stages of cirrhosis. These disease\u2010related factors and the possibility of a limited therapeutic window should be considered in future studies evaluating the use of anticoagulants in cirrhosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/liv.13510","type":"journal-article","created":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T11:52:51Z","timestamp":1498823571000},"page":"102-112","source":"Crossref","is-referenced-by-count":22,"title":["Enoxaparin does not ameliorate liver fibrosis or portal hypertension in rats with advanced cirrhosis"],"prefix":"10.1111","volume":"38","author":[{"given":"Jos\u00e9 I.","family":"Fortea","sequence":"first","affiliation":[{"name":"Laboratorio Investigaci\u00f3n Hepatolog\u00eda y Gastroenterolog\u00eda HGU Gregorio Mara\u00f1\u00f3n  Madrid Spain"},{"name":"Instituto Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zipprich","sequence":"additional","affiliation":[{"name":"Innere Medizin I Martin\u2010Luther\u2010Universit\u00e4t Halle\u2010Wittenberg  Halle Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Fernandez\u2010Mena","sequence":"additional","affiliation":[{"name":"Laboratorio Investigaci\u00f3n Hepatolog\u00eda y Gastroenterolog\u00eda HGU Gregorio Mara\u00f1\u00f3n  Madrid Spain"},{"name":"Instituto Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Puerto","sequence":"additional","affiliation":[{"name":"Laboratorio Investigaci\u00f3n Hepatolog\u00eda y Gastroenterolog\u00eda HGU Gregorio Mara\u00f1\u00f3n  Madrid Spain"},{"name":"Instituto Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM)  Madrid Spain"},{"name":"CIBERehd  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina R.","family":"Bosoi","sequence":"additional","affiliation":[{"name":"Hepato\u2010neuro laboratory CRCHUM Universit\u00e9 de Montr\u00e9al  Montr\u00e9al Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Almagro","sequence":"additional","affiliation":[{"name":"Laboratorio Investigaci\u00f3n Hepatolog\u00eda y Gastroenterolog\u00eda HGU Gregorio Mara\u00f1\u00f3n  Madrid Spain"},{"name":"Instituto Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Hollenbach","sequence":"additional","affiliation":[{"name":"Innere Medizin I Martin\u2010Luther\u2010Universit\u00e4t Halle\u2010Wittenberg  Halle Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Ba\u00f1ares","sequence":"additional","affiliation":[{"name":"Laboratorio Investigaci\u00f3n Hepatolog\u00eda y Gastroenterolog\u00eda HGU Gregorio Mara\u00f1\u00f3n  Madrid Spain"},{"name":"Instituto Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Rodr\u00edguez\u2010S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Instituto Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM)  Madrid Spain"},{"name":"Microbiolog\u00eda Cl\u00ednica y Enfermedades Infecciosas HGU Gregorio Mara\u00f1\u00f3n  Madrid Spain"},{"name":"CIBERES  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Cercenado","sequence":"additional","affiliation":[{"name":"Instituto Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM)  Madrid Spain"},{"name":"Microbiolog\u00eda Cl\u00ednica y Enfermedades Infecciosas HGU Gregorio Mara\u00f1\u00f3n  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc\u2010Andr\u00e9","family":"Cl\u00e9ment","sequence":"additional","affiliation":[{"name":"Hepato\u2010neuro laboratory CRCHUM Universit\u00e9 de Montr\u00e9al  Montr\u00e9al Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9854-6834","authenticated-orcid":false,"given":"Christopher F.","family":"Rose","sequence":"additional","affiliation":[{"name":"Hepato\u2010neuro laboratory CRCHUM Universit\u00e9 de Montr\u00e9al  Montr\u00e9al Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0412-8437","authenticated-orcid":false,"given":"Rafael","family":"Ba\u00f1ares","sequence":"additional","affiliation":[{"name":"Laboratorio Investigaci\u00f3n Hepatolog\u00eda y Gastroenterolog\u00eda HGU Gregorio Mara\u00f1\u00f3n  Madrid Spain"},{"name":"Instituto Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM)  Madrid Spain"},{"name":"CIBERehd  Madrid Spain"},{"name":"Facultad de Medicina Universidad Complutense  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8903-7288","authenticated-orcid":false,"given":"Javier","family":"Vaquero","sequence":"additional","affiliation":[{"name":"Laboratorio Investigaci\u00f3n Hepatolog\u00eda y Gastroenterolog\u00eda HGU Gregorio Mara\u00f1\u00f3n  Madrid Spain"},{"name":"Instituto Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM)  Madrid Spain"},{"name":"CIBERehd  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Ripoll","sequence":"additional","affiliation":[{"name":"Laboratorio Investigaci\u00f3n Hepatolog\u00eda y Gastroenterolog\u00eda HGU Gregorio Mara\u00f1\u00f3n  Madrid Spain"},{"name":"Instituto Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM)  Madrid Spain"},{"name":"Innere Medizin I Martin\u2010Luther\u2010Universit\u00e4t Halle\u2010Wittenberg  Halle Germany"},{"name":"CIBERehd  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,9,30]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25915"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1550440"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840210505"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.039"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.07.018"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.05959.x"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2006.apm_235.x"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/00024382-199607000-00010"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v9.i7.1611"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2004.04.009"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.08.023"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-006-9595-1"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1665-2681(19)31621-7"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.12.003"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.6943"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24273"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.01.032"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.06.027"},{"key":"e_1_2_9_20_1","first-page":"341","article-title":"The heparin target organ\u2013the endothelium. Studies in a rat model","volume":"86","author":"Hiebert LM","year":"1993","journal-title":"Q J Med"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.95.8.2115"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.22.2861"},{"issue":"92","key":"e_1_2_9_23_1","first-page":"2012","article-title":"Role of nitric oxide in heparin\u2010induced attenuation of hypoxic pulmonary vascular remodeling","volume":"2002","author":"Horstman DJ","year":"1985","journal-title":"J Appl Physiol"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.fjc.0000159878.66325.fc"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116805"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(91)90135-J"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199207163270301"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fliv.13510","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/liv.13510","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T07:45:48Z","timestamp":1695541548000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/liv.13510"}},"subtitle":[],"editor":[{"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,9,30]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1111\/liv.13510"],"URL":"https:\/\/doi.org\/10.1111\/liv.13510","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727762992.793547487","asserted-by":"object"}]},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,30]]}}}